Response by Fearon et al to Letter Regarding Article, “Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial”

William F. Fearon; Kuniaki Takahashi; Kiran K. Khush

doi:10.1161/circulationaha.126.080757

Response by Fearon et al to Letter Regarding Article, “Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial”

W William F. Fearon (Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, Stanford, CA) K Kuniaki Takahashi (Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, CA, (W.F.F., K.T., K.K.K.).) K Kiran K. Khush (Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, CA, (W.F.F., K.T., K.K.K.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 154, Issue 5

Published August 04, 2026

DOI 10.1161/circulationaha.126.080757

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

W

William F. Fearon

Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, Stanford, CA

K

Kuniaki Takahashi

Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, CA, (W.F.F., K.T., K.K.K.).

K

Kiran K. Khush

Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, CA, (W.F.F., K.T., K.K.K.).

Response by Fearon et al to Letter Regarding Article, “Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial”

Article Details

Journal Info

Authors (3)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”